Immunoglobulin E Antibodies to Rocuronium
- 1 August 2007
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Anesthesiology
- Vol. 107 (2), 253-259
- https://doi.org/10.1097/01.anes.0000270735.40872.f2
Abstract
Background Diagnosis of allergy from neuromuscular blocking agents is not always straightforward. The objectives of the current study were to investigate the value of quantification of immunoglobulin E (IgE) by ImmunoCAP (Phadia AB, Uppsala, Sweden) in the diagnosis of rocuronium allergy and to study whether IgE inhibition tests can predict clinical cross-reactivity between neuromuscular blocking agents. Methods Twenty-five rocuronium-allergic patients and 30 control individuals exposed to rocuronium during uneventful anesthesia were included. Thirty-two sera (total IgE > 1,500 kU/l) were analyzed for potential interference of elevated total IgE titers. Results were compared with quantification of IgE for suxamethonium, morphine, and pholcodine. Cross-reactivity between drugs was assessed by IgE inhibition and skin tests. Results Sensitivity of IgE for rocuronium, suxamethonium, morphine, and pholcodine was 68, 60, 88, and 86%, respectively. Specificity was 100% for suxamethonium, morphine, and pholcodine IgE and 93% for rocuronium IgE. ROC analysis between patients and control individuals changed the threshold to 0.13 kUa/l for rocuronium, 0.11 kUa/l for suxamethonium, 0.36 kUa/l for morphine, and 0.43 kUa/l for pholcodine. Corresponding sensitivity was 92, 72, 88, and 86%, respectively. Specificity was unaltered. Interference of elevated total IgE with quantification of IgE was demonstrated by the analysis in sera with a total IgE greater than 1,500 kU/l. IgE inhibition did not predict clinical relevant cross-reactivity. Conclusions The rocuronium ImmunoCAP constitutes a reliable technique to diagnose rocuronium allergy, provided an assay-specific decision threshold is applied. IgE assays based on compounds bearing ammonium epitopes are confirmed to represent reliable tools to diagnose rocuronium allergy. High total IgE titers were observed to affect specificity of the assays.Keywords
This publication has 32 references indexed in Scilit:
- Flow‐assisted allergy diagnosis: current applications and future perspectivesAllergy, 2006
- Flow cytometric investigation of peri‐anaesthetic anaphylaxis using CD63 and CD203cAnaesthesia, 2005
- Skin Sensitivity to Rocuronium and Vecuronium: A Randomized Controlled Prick-Testing Study in Healthy VolunteersAnesthesia & Analgesia, 2004
- In vitro allergy diagnosis: should we follow the flow?Clinical and Experimental Allergy, 2004
- Monitoring of Basophil Activation Using CD63 and CCR3 in Allergy to Muscle Relaxant DrugsClinical Immunology, 2002
- Weal and flare responses to intradermal rocuronium and cisatracurium in humansBritish Journal of Anaesthesia, 2000
- Validation of a flow cytometric assay detecting in vitro basophil activation for the diagnosis of muscle relaxant allergyJournal of Allergy and Clinical Immunology, 1999
- Failure to prevent an anaphylactic reaction to a second neuromuscular blocking drug during anaesthesiaBritish Journal of Anaesthesia, 1999
- Subsequent General Anaesthesia in Patients with a History of Previous Anaphylactoid/Anaphlactic Reaction to Muscle RelaxantAnaesthesia and Intensive Care, 1999
- Skin testing in the investigation of reactions to intravenous anaesthetic drugs. A prospective trial of atracurium and tubocurarineAnnales Françaises dʼAnesthésie et de Réanimation, 1985